GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dev Information Technology Ltd

Dev IT wins INR 26 Crore order from NICSI for Pharmacy Council platform

ORDERS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 09 Apr 2026, 02:00 PM IST  ·  BSE ID: a6a9c09e-000b-4109-affa-5518e5f96716
View Original BSE Filing (PDF)
💡
In Simple Terms
The company just won a INR 26 Crore government contract to build and maintain a pharmacy registration system for India's Pharmacy Council.
🤖 AI Summary
  • Dev IT awarded INR 26 Crore order from NICSI for Pharmacy Council of India platform
  • Scope: design, development, integration, maintenance of software, applications, cybersecurity services
  • Includes National Pharmacists Registration Tracking System web-based infrastructure development
  • Fixed-cost domestic contract from state entity (government of India statutory body)
  • Filed under Regulation 30 LODR — material event disclosure
🔢 Key Numbers — exact figures from BSE filing, not rounded
Order Value
INR 26 Crore
Order Type
Fixed-cost
Client Entity
National Informatics Centre Services Incorporated (NICSI) on behalf of Pharmacy Council of India
Order Category
Domestic (State entity)
🏢 How This Affects the Company
📈
Business Impact
Order adds recurring revenue stream from government sector through cybersecurity and software maintenance services for a national registration platform. Expands public sector footprint and validates capability to execute large-scale government IT projects.
💰
Financial Impact
INR 26 Crore fixed-cost contract will contribute to top-line revenue recognition over project execution period. Fixed-cost nature means margins depend on execution efficiency and cost management.
⚙️
Operational Impact
Project requires capability to design, develop, integrate, and maintain software platforms plus cybersecurity services. Implies need for cybersecurity and software development team deployment across project duration.
⚠️
Risk Impact
Fixed-cost contract structure creates margin risk if project scope expands or delivery timelines slip. Government entity dependency adds execution timeline and approval risk inherent to public sector projects.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor Q1 FY27 results filing for project commencement confirmation and revenue recognition schedule.
👤
Who Is Affected
All shareholders benefit from INR 26 Crore revenue pipeline and improved government sector credibility, though actual earnings impact depends on project execution and margin delivery.
🔍
Management Signal
Order win demonstrates management's ability to compete and win large-scale government IT contracts, signaling confidence in cybersecurity and software development capabilities.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 quarterly results — confirm project commencement and revenue recognition schedule
Disclosure of project execution timeline and key milestones in investor presentations or updates
Subsequent order wins in government/healthcare sectors indicating competitive strength in public tenders
MEDIUM RISK Fixed-cost structure creates margin risk on cost overruns. Government project execution timelines and approval dependencies add execution uncertainty.
💡 Investor Takeaway
Dev IT secured INR 26 Crore fixed-cost government order from Pharmacy Council of India for platform development, integration, and cybersecurity. Government client provides revenue certainty but fixed pricing constrains margin upside. Project execution timeline and margin outcomes critical to track in upcoming quarterly results.
⚖️ Strengths & Concerns

✅ Positives

  • Government client (Pharmacy Council of India) provides payment certainty and public sector credibility for future bidding
  • Multi-service scope (development, integration, maintenance, cybersecurity) indicates breadth of technical capabilities recognized

⚠️ Concerns

  • Fixed-cost contract limits upside if project complexity increases — cost overruns directly impact margins
  • No disclosed timeline or payment milestones — execution duration and cash flow phasing unclear from filing
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.